Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination.
- Author:
Sangho LIM
1
;
Ja Hyun KOO
;
Je Min CHOI
Author Information
- Publication Type:Review
- Keywords: Cell-penetrating peptide; Dendritic cell; Vaccination; Immune modulation
- MeSH: Amino Acids; Antigen Presentation; Cell-Penetrating Peptides*; Dendritic Cells; DNA; Immune System Diseases; Immunotherapy; Peptides; RNA; Vaccination*; Vaccines
- From:Immune Network 2016;16(1):33-43
- CountryRepublic of Korea
- Language:English
- Abstract: Cell-penetrating peptides (CPPs) are short amino acids that have been widely used to deliver macromolecules such as proteins, peptides, DNA, or RNA, to control cellular behavior for therapeutic purposes. CPPs have been used to treat immunological diseases through the delivery of immune modulatory molecules in vivo. Their intracellular delivery efficiency is highly synergistic with the cellular characteristics of the dendritic cells (DCs), which actively uptake foreign antigens. DC-based vaccines are primarily generated by pulsing DCs ex vivo with various immunomodulatory antigens. CPP conjugation to antigens would increase DC uptake as well as antigen processing and presentation on both MHC class II and MHC class I molecules, leading to antigen specific CD4+ and CD8+ T cell responses. CPP-antigen based DC vaccination is considered a promising tool for cancer immunotherapy due to the enhanced CTL response. In this review, we discuss the various applications of CPPs in immune modulation and DC vaccination, and highlight the advantages and limitations of the current CPP-based DC vaccination.
